Clinical Trials on Non Hodgkin´s Lymphomas
Total 5333 results
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
NCIC Clinical Trials GroupEli Lilly and CompanyCompleted
-
Autolus LimitedRecruitingAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T Cell Non-Hodgkin Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedUnited Kingdom, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Bristol-Myers SquibbActive, not recruiting
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
The Methodist Hospital Research InstituteWithdrawnNon-Hodgkin Lymphoma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Mirati Therapeutics Inc.CompletedNon Hodgkin's Lymphoma | TumorsCanada, United States
-
German High-Grade Non-Hodgkin's Lymphoma Study...Deutsche Krebshilfe e.V., Bonn (Germany)CompletedNon-Hodgkin's Lymphoma (NHL)Germany
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.CompletedRelapse | Lymphomas Non-Hodgkin's B-CellChina
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Vittoria BiotherapeuticsUniversity of PennsylvaniaNot yet recruitingT Cell Non-Hodgkin LymphomaUnited States
-
Sinocelltech Ltd.Not yet recruitingNon-Hodgkin Lymphoma, B-cellChina
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGRecruiting
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Gilead SciencesOno Pharmaceutical Co. LtdCompletedChronic Lymphocytic Leukaemia | Non Hodgkins LymphomaUnited Kingdom, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...WithdrawnStage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Human Immunodeficiency Virus 1 Positive | Stage I Adult Hodgkin Lymphoma | Stage II Adult Hodgkin Lymphoma | Stage I Adult Non-Hodgkin Lymphoma | Stage II Adult Non-Hodgkin Lymphoma | Stage III Adult Non-Hodgkin Lymphoma | Stage IV...United States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
Debiopharm International SACompletedDiffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's LymphomaUnited States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Marcela V. Maus, M.D.,Ph.D.Kite, A Gilead CompanyActive, not recruitingNon Hodgkin Lymphoma | Neurotoxicity | Neurotoxicity Syndromes | Cytokine Release Syndrome | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditionsUnited States, Germany
-
Zhejiang UniversityYake Biotechnology Ltd.Not yet recruitingRelapsed and/or Refractory Acute Lymphoblastic Leukemia | Relapsed and/or Refractory B-cell Non-Hodgkin's LymphomaChina
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Vinmec Research Institute of Stem Cell and Gene...National Institute of Hematology and Blood Transfusion, VietnamRecruitingB-Cell Non Hodgkin Lymphoma | B-Cell Acute Lymphoblastic LeukemiaVietnam
-
University of Colorado, DenverNational Cancer Institute (NCI)RecruitingB-cell Acute Lymphoblastic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin LymphomaUnited States
-
Gilead SciencesThe Leukemia and Lymphoma SocietyTerminatedNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Acerta Pharma BVAstraZenecaActive, not recruitingNon Hodgkin LymphomaUnited States, Canada, Italy
-
University of Colorado, DenverActive, not recruiting
-
Stanford UniversityNational Institutes of Health (NIH)CompletedLymphoma, Non-Hodgkin | Blood and Marrow Transplant (BMT) | Lymphomas: Non-HodgkinUnited States
-
Genzyme, a Sanofi CompanyCompletedLymphoma | Multiple Myeloma | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruiting
-
Acibadem UniversityThe Scientific and Technological Research Council of Turkey; Acıbadem Labcell; Acıbadem Atunizade HospitalUnknownStudy of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL (ISIKOK-19)Acute Lymphoblastic Leukemia | Non Hodgkin LymphomaTurkey
-
Beth ChristianGilead SciencesCompleted
-
Technical University of MunichUnknown
-
Bristol-Myers SquibbTerminatedAdvanced Solid Tumors | Advanced B-cell NHLUnited States, France, Spain, Germany
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel, United Kingdom
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
920th Hospital of Joint Logistics Support Force...Gracell Biotechnology Shanghai Co., Ltd.; Kunming Hope of Health HospitalRecruitingRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B-cell Non-hodgkin LymphomaChina
-
Genentech, Inc.TerminatedMultiple Myeloma | Non-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Korea, Republic of